Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.27 | 1e-05 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |